These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1634046)

  • 41. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation?
    Kim WH; Lee JH; Han SU; Wang HJ; Kim MW
    Hepatogastroenterology; 1998; 45(24):2425-9. PubMed ID: 9951937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.
    Ménoret S; Aubert D; Tesson L; Braudeau C; Pichard V; Ferry N; Anegon I
    Hum Gene Ther; 2002 Jul; 13(11):1383-90. PubMed ID: 12162820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells.
    De Geest BR; Van Linthout SA; Collen D
    Blood; 2003 Apr; 101(7):2551-6. PubMed ID: 12446451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
    J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Backes S; Jäger C; Dembek CJ; Kosinska AD; Bauer T; Stephan AS; Dišlers A; Mutwiri G; Busch DH; Babiuk LA; Gasteiger G; Protzer U
    Vaccine; 2016 Feb; 34(7):923-32. PubMed ID: 26776470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
    Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents.
    Rajvanshi P; Kerr A; Bhargava KK; Burk RD; Gupta S
    Gastroenterology; 1996 Oct; 111(4):1092-1102. PubMed ID: 8831605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
    Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule.
    Rajvanshi P; Kerr A; Bhargava KK; Burk RD; Gupta S
    Hepatology; 1996 Mar; 23(3):482-96. PubMed ID: 8617428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.
    Bian Y; Zhang Z; Sun Z; Zhao J; Zhu D; Wang Y; Fu S; Guo J; Liu L; Su L; Wang FS; Fu YX; Peng H
    Hepatology; 2017 Oct; 66(4):1067-1082. PubMed ID: 28445927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization against hepatitis B through adoptive transfer of immunity.
    Shouval D; Ilan Y
    Intervirology; 1995; 38(1-2):41-6. PubMed ID: 8666523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization with HBsAg-Fc fusion protein induces a predominant production of Th1 cytokines and reduces HBsAg level in transgenic mice.
    Meng ZF; Wang HJ; Yao X; Wang XY; Wen YM; Dai JX; Xie YH; Xu JQ
    Chin Med J (Engl); 2012 Sep; 125(18):3266-72. PubMed ID: 22964321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.